United Kingdom · Delayed Price · Currency is GBP · Price in GBX Bioventix Statistics
Total Valuation
Bioventix has a market cap or net worth of GBP 105.80 million. The enterprise value is 100.54 million.
| Market Cap | 105.80M |
| Enterprise Value | 100.54M |
Important Dates
The next estimated earnings date is Thursday, December 24, 2026.
| Earnings Date | Dec 24, 2026 |
| Ex-Dividend Date | Nov 5, 2026 |
Share Statistics
Bioventix has 5.22 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 5.22M |
| Shares Outstanding | 5.22M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 6.18% |
| Owned by Institutions (%) | 61.56% |
| Float | 4.15M |
Valuation Ratios
The trailing PE ratio is 14.10 and the forward PE ratio is 14.14.
| PE Ratio | 14.10 |
| Forward PE | 14.14 |
| PS Ratio | 8.16 |
| PB Ratio | 9.27 |
| P/TBV Ratio | 9.27 |
| P/FCF Ratio | 13.42 |
| P/OCF Ratio | 13.30 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.97, with an EV/FCF ratio of 12.75.
| EV / Earnings | 13.20 |
| EV / Sales | 7.75 |
| EV / EBITDA | 9.97 |
| EV / EBIT | 10.03 |
| EV / FCF | 12.75 |
Financial Position
The company has a current ratio of 8.53, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.53 |
| Quick Ratio | 4.78 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | 71,607.35 |
Financial Efficiency
Return on equity (ROE) is 66.31% and return on invested capital (ROIC) is 121.27%.
| Return on Equity (ROE) | 66.31% |
| Return on Assets (ROA) | 48.78% |
| Return on Invested Capital (ROIC) | 121.27% |
| Return on Capital Employed (ROCE) | 87.76% |
| Weighted Average Cost of Capital (WACC) | 7.09% |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | 634,554 |
| Employee Count | 12 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 1.59 |
Taxes
In the past 12 months, Bioventix has paid 2.61 million in taxes.
| Income Tax | 2.61M |
| Effective Tax Rate | 25.55% |
Stock Price Statistics
The stock price has decreased by -6.30% in the last 52 weeks. The beta is 0.52, so Bioventix's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -6.30% |
| 50-Day Moving Average | 1,745.86 |
| 200-Day Moving Average | 1,664.44 |
| Relative Strength Index (RSI) | 67.14 |
| Average Volume (20 Days) | 19,769 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioventix had revenue of GBP 12.97 million and earned 7.61 million in profits. Earnings per share was 1.44.
| Revenue | 12.97M |
| Gross Profit | 11.86M |
| Operating Income | 10.03M |
| Pretax Income | 10.23M |
| Net Income | 7.61M |
| EBITDA | 10.08M |
| EBIT | 10.03M |
| Earnings Per Share (EPS) | 1.44 |
Balance Sheet
The company has 5.26 million in cash and 3,816 in debt, with a net cash position of 5.26 million or 1.01 per share.
| Cash & Cash Equivalents | 5.26M |
| Total Debt | 3,816 |
| Net Cash | 5.26M |
| Net Cash Per Share | 1.01 |
| Equity (Book Value) | 11.42M |
| Book Value Per Share | 2.18 |
| Working Capital | 10.57M |
Cash Flow
In the last 12 months, operating cash flow was 7.95 million and capital expenditures -71,599, giving a free cash flow of 7.88 million.
| Operating Cash Flow | 7.95M |
| Capital Expenditures | -71,599 |
| Depreciation & Amortization | 55,081 |
| Net Borrowing | n/a |
| Free Cash Flow | 7.88M |
| FCF Per Share | 1.51 |
Margins
Gross margin is 91.45%, with operating and profit margins of 77.28% and 58.70%.
| Gross Margin | 91.45% |
| Operating Margin | 77.28% |
| Pretax Margin | 78.84% |
| Profit Margin | 58.70% |
| EBITDA Margin | 77.71% |
| EBIT Margin | 77.28% |
| FCF Margin | 60.77% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 7.41%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 7.41% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 102.92% |
| FCF Payout Ratio | 99.42% |
| Buyback Yield | -0.17% |
| Shareholder Yield | 7.23% |
| Earnings Yield | 7.09% |
| FCF Yield | 7.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bioventix has an Altman Z-Score of 50.14 and a Piotroski F-Score of 6.
| Altman Z-Score | 50.14 |
| Piotroski F-Score | 6 |